141 related articles for article (PubMed ID: 19513837)
1. Omeprazole induces gastric permeability to digoxin.
Gabello M; Valenzano MC; Barr M; Zurbach P; Mullin JM
Dig Dis Sci; 2010 May; 55(5):1255-63. PubMed ID: 19513837
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole induces gastric transmucosal permeability to the peptide bradykinin.
Gabello M; Valenzano MC; Zurbach EP; Mullin JM
World J Gastroenterol; 2010 Mar; 16(9):1097-103. PubMed ID: 20205280
[TBL] [Abstract][Full Text] [Related]
3. Transmucosal gastric leak induced by proton pump inhibitors.
Murray LJ; Gabello M; Rudolph DS; Farrell CP; Morgan M; Martin AP; Underwood JC; Valenzano MC; Mullin JM
Dig Dis Sci; 2009 Jul; 54(7):1408-17. PubMed ID: 19015985
[TBL] [Abstract][Full Text] [Related]
4. Effect of proton pump inhibitors on the secretion of bicarbonates and pepsinogen induced by chemical stimulation of the gastric mucosa.
Zolotarev VA; Khropycheva RP
Bull Exp Biol Med; 2013 Feb; 154(4):415-8. PubMed ID: 23486568
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue.
Hopkins AM; McDonnell C; Breslin NP; O'Morain CA; Baird AW
J Pharm Pharmacol; 2002 Mar; 54(3):341-7. PubMed ID: 11902800
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of a single dose of omeprazole or lansoprazole on intragastric pH in Japanese participants: a two-way crossover study.
Funaki Y; Tokudome K; Izawa S; Tamura Y; Kondo Y; Iida A; Mizuno M; Ogasawara N; Sasaki M; Kasugai K
J Chin Med Assoc; 2013 Mar; 76(3):131-4. PubMed ID: 23497964
[TBL] [Abstract][Full Text] [Related]
9. Increased hepatocyte growth factor content in rat stomach during omeprazole treatment.
Kinoshita Y; Hassan MS; Kawamura M; Matsushima Y; Okada A; Maekawa T; Fukui H; Waki S; Kishi K; Chiba T
Digestion; 1998; 59(2):102-9. PubMed ID: 9586821
[TBL] [Abstract][Full Text] [Related]
10. Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats.
Giraud MN; Sanduja SK; Felder TB; Illich PA; Dial EJ; Lichtenberger LM
Aliment Pharmacol Ther; 1997 Oct; 11(5):899-906. PubMed ID: 9354198
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.
Konagaya T; Bernsand M; Norlén P; Håkanson R
Br J Pharmacol; 2001 May; 133(1):37-42. PubMed ID: 11325792
[TBL] [Abstract][Full Text] [Related]
12. Administration of erlotinib in apple juice overcomes decreased absorption in a rat model of gastric acid suppression.
Shimada T; Okano M; Yamada M; Ogawa Y; Ueda A; Nagase K; Sai Y
Drug Metab Pharmacokinet; 2020 Dec; 35(6):534-538. PubMed ID: 33028492
[TBL] [Abstract][Full Text] [Related]
13. Cadmium inhibits acid secretion in stimulated frog gastric mucosa.
Gerbino A; Debellis L; Caroppo R; Curci S; Colella M
Toxicol Appl Pharmacol; 2010 Jun; 245(2):264-71. PubMed ID: 20307561
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
[TBL] [Abstract][Full Text] [Related]
15. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
16. Effects of acid inhibition on somatostatin-producing cells in the rat gastric fundus.
Bolkent S; Yilmazer S; Kaya F; Oztürk M
Acta Histochem; 2001 Oct; 103(4):413-22. PubMed ID: 11700946
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
18. Effects of omeprazole on rat gastric mucus glycoproteins with acetylsalicylic acid-induced gastric damage.
Ohara S; Murayama N; Kuwata H; Ishihara K; Hotta K
Arch Int Pharmacodyn Ther; 1988; 296():192-201. PubMed ID: 3240017
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole on eicosanoid formation in and release from guinea-pig gastric mucosal cells.
Hell M; Sewing KF
Br J Pharmacol; 1987 May; 91(1):69-75. PubMed ID: 3297228
[TBL] [Abstract][Full Text] [Related]
20. Interaction of omeprazole and Helicobacter pylori-induced nuclear factor-κB activation and mediators in gastric epithelial cells.
Peng YC; Huang LR; Shyu CL; Cheng CC; Ho SP
J Chin Med Assoc; 2014 Nov; 77(11):567-72. PubMed ID: 25205289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
